Key result
In a cohort of 22 patients with SCN1A-related epilepsy, 22 variants were identified including 12 novel mutations, with 72.7% of patients presenting with Dravet syndrome.
Why the study?
The study was conducted to expand the genotypes and phenotypes of SCN1A-related epilepsy.
Cohort (n=22)
No
The study expands the known genotypic and phenotypic spectrum of SCN1A-related epilepsy by identifying 12 novel variants and describing rare phenotypes.
Answers are grounded in this paper and cite their sources.
Adds novel SCN1A variants; extends spectrum but remains hypothesis-generating and should not change practice.
Objectives: To expand the genotypes and phenotypes of sodium voltage-gated channel alpha subunit 1 (SCN1A)-related epilepsy. Methods: We retrospectively collected the clinical and genetic information of 22 epilepsy patients (10 males, 12 females; mean: 9.2 ± 3.9 years; 3.9-20.3 years) carrying 22 variants of SCN1A. SCN1A mutations were identified by next-generation sequencing. Results: Twenty-two variants were identified, among which 12 have not yet been reported. The median age at seizure onset was 6 months. Sixteen patients were diagnosed with Dravet syndrome (DS), two with genetic epilepsy with febrile seizures plus [one evolved into benign epilepsy with centrotemporal spikes (BECTS)], one with focal epilepsy, one with atypical childhood epilepsy with centrotemporal spikes (ABECTS) and two with unclassified epilepsy. Fourteen patients showed a global developmental delay/intellectual disability (GDD/ID). Slow background activities were observed in one patient and epileptiform discharges were observed in 11 patients during the interictal phase. Significance: This study enriches the genotypes and phenotypes of SCN1A-related epilepsy. The clinical characteristics of patients with 12 previously unreported variants were described.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2022) conducted a cohort in SCN1A-related epilepsy (n=22). SCN1A mutations was evaluated. In a cohort of 22 patients with SCN1A-related epilepsy, 22 variants were identified including 12 novel mutations, with 72.7% of patients presenting with Dravet syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: